Maryland Biotechnology Company MetaMorphixIs Named "Business Leader" In Agriculture On The 2004 "Scientific American 50"
Prestigious List Recognizes Science and Technology Contributions from Many Fields
Selected by the magazine's Board of Editors with the help of distinguished outside advisors, the Scientific American 50 spotlights Research, Business and Policy Leaders in various technological categories. MetaMorphix, Inc. has been named Business Leader in Agriculture because of work over the last year in livestock genomics.
Edwin C. Quattlebaum, Chairman and CEO of MetaMorphix said: "To be named as a Business Leader in Agriculture on the Scientific American 50, with its singular stature in the world of science and technology is a great honor. We are delighted to be recognized for our work on building our extensive database of SNP markers and on completing, to our knowledge, the first association study in a livestock species, beef cattle."
MetaMorphix, Inc. has established research and development programs to develop and commercialize tools to identify cattle bearing traits that satisfy consumer demands for consistency and quality in beef. This past year, MMI identified and characterized a dense map of novel genetic markers based on single nucleotide polymorphisms (SNPs) in beef cattle using its GENIUS Whole Genome System(TM). The Company then conducted a whole genome association study in a large population of commercial beef cattle at a feedlot and discovered specific regions in the cattle genome that associate with desirable beef traits. Over fourteen million genotyping assays were generated during the extensive research program.
Founded in 1994 and based in Savage, Maryland, MetaMorphix, Inc. is a privately-held life sciences company that uses the code of life DNA to improve the global food supply and human health. In livestock, the Company helps customers produce higher quality, nutritious meat more efficiently; and in healthcare, discovers and licenses targets to pharmaceutical companies that develop therapies for better management of metabolic and muscular degenerative diseases.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.